Reference health
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
19/19 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
12 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 19 checked references that resolve
resolves10.1136/annrheumdis-2020-217877
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
resolves10.1136/annrheumdis-2020-219773
EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
resolves10.1136/annrheumdis-2014-206350
2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
resolves10.1136/annrheumdis-2021-221575
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
resolves10.1136/annrheumdis-2021-219845
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
resolves10.1093/rheumatology/keaa897
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark
resolves10.1136/annrheumdis-2020-219498
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
resolves10.1136/annrheumdis-2021-220418
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
resolves10.1136/annrheumdis-2020-218019
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs
resolves10.1016/S2665-9913(20)30389-1
Variability in counselling for adrenal insufficiency in COVID-19 and beyond: a survey of rheumatology practice
resolves10.1136/annrheumdis-2013-203249
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
resolves10.1002/art.41596
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
resolves10.1136/annrheumdis-2020-219724
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
resolves10.1136/annrheumdis-2021-221366
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
resolves10.1136/rmdopen-2021-001899
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
resolves10.1136/annrheumdis-2020-219725
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
resolves10.1136/annrheumdis-2019-215882
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
resolves10.1002/art.41301
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1
The 12 references without a DOI — listed, not checked
no DOI — not checkedResponse to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry“ by Mulhearn et al
no DOI — not checkedA living who guideline on drugs for covid-19
no DOI — not checked10.1136/annrheumdis-2021-222006_bib12
no DOI — not checked10.1136/annrheumdis-2021-222006_bib13
no DOI — not checked10.1136/annrheumdis-2021-222006_bib14
no DOI — not checked10.1136/annrheumdis-2021-222006_bib15
no DOI — not checked10.1136/annrheumdis-2021-222006_bib16
no DOI — not checked10.1136/annrheumdis-2021-222006_bib17
no DOI — not checkedAmerican College of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 3
no DOI — not checkedOdds of testing positive for SARS-CoV-2 following receipt of 3 vs 2 doses of the BNT162b2 mRNA vaccine
no DOI — not checked10.1136/annrheumdis-2021-222006_bib30
no DOI — not checked10.1136/annrheumdis-2021-222006_bib31
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-222006"><img src="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-222006/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1136/annrheumdis-2021-222006)